|
VPS33A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.682200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.525400E-01 |
| Normal-vs-Stage2 |
1.444560E-01 |
| Normal-vs-Stage3 |
1.819600E-02 |
| Normal-vs-Stage4 |
3.806600E-01 |
| Stage1-vs-Stage2 |
4.843600E-01 |
| Stage1-vs-Stage3 |
5.357800E-02 |
| Stage1-vs-Stage4 |
5.959000E-01 |
| Stage2-vs-Stage3 |
2.620400E-01 |
| Stage2-vs-Stage4 |
8.767400E-01 |
| Stage3-vs-Stage4 |
5.350200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.685700E-02 |
| Normal-vs-AfricanAmerican |
1.995560E-02 |
| Normal-vs-Asian |
4.229400E-01 |
| Caucasian-vs-AfricanAmerican |
5.835200E-01 |
| Caucasian-vs-Asian |
6.258400E-01 |
| AfricanAmerican-vs-Asian |
6.885400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.189600E-02 |
| Normal-vs-Female |
3.429200E-04 |
| Male-vs-Female |
1.385680E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.996170E-01 |
| Normal-vs-Extreme_Weight |
8.039000E-01 |
| Normal-vs-Obese |
4.076100E-02 |
| Normal-vs-Extreme_Obese |
6.321000E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.728360E-01 |
| Normal_Weight-vs-Obese |
6.810800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.386000E-01 |
| Extreme_Weight-vs-Obese |
3.662100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.994200E-01 |
| Obese-vs-Extreme_Obese |
2.259200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.917000E-03 |
| Normal-vs-Age(41-60Yrs) |
4.318900E-03 |
| Normal-vs-Age(61-80Yrs) |
2.141600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.892800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.607020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.719500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.569700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.553790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.693000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.082000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.010380E-01 |
| Normal-VS-Type2 PRCC |
2.192200E-02 |
| Normal-VS-KIRP CIMP |
8.387600E-02 |
| Normal-VS-Unclassified PRCC |
1.264210E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.806630E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.276400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.472300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.548000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.514000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.656400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.674800E-01 |
| Normal-vs-N1 |
3.658900E-03 |
| Normal-vs-N2 |
3.637000E-01 |
| N0-vs-N1 |
2.082100E-02 |
| N0-vs-N2 |
9.332000E-01 |
| N1-vs-N2 |
3.336200E-01 |
|
|
